Stockreport

Does Short Squeeze Attention and AI Advances Alter the Bull Case for Recursion Pharmaceuticals (RXRX)? [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF short interest, alongside the announcement of a $12.5 million milestone payment from Rallybio related to the advancement of REV102 for hypophosphatasia. An intriguing [Read more]